Azzad Asset Management’s Guardant Health GH Stock Holding History

Azzad Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,224	Closed	-$346K	–	398
2022 Q1	$346K	Hold	5,224	–	–	0.05%	296
2021 Q4	$523K	Hold	5,224	–	–	0.07%	287
2021 Q3	$653K	Buy	5,224 +126	+2%	+$15K	0.1%	270
2021 Q2	$633K	Hold	5,098	–	–	0.09%	272
2021 Q1	$778K	Buy	+5,098	New	+$770K	0.13%	237

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Azzad Asset Management's GH Position: Q2 2022 in Review

Azzad Asset Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 5,224 shares — an estimated $346K sold.

Azzad Asset Management first reported a position in GH in Q1 2021 and held it in 5 quarters. The position peaked at $778K in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Azzad Asset Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Azzad Asset Management sold 5,224 Guardant Health shares in Q2 2022, an estimated $346K.
Azzad Asset Management first reported a position in Guardant Health in Q1 2021 and held it in 5 quarters.
Azzad Asset Management's Guardant Health position peaked at $778K in Q1 2021.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Azzad Asset Management's 13F filing for Q2 2022, filed 1 Apr 2024.